EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 3.0

Real-World Identification of Eosinophilic COPD Patients Potentially Eligible for Dupilumab: A Retrospective Observational Study

Nicoletta Di Giorgi iD, Ilaria Barisone iD, Jasmine Nour, Devis Moretti, Andrea Pagliai, Alfredo Cesario, Angela Nervoso iD, Angelo Coppola, Edoardo Pompei, Chiara Iacomini, Carlotta Masciocchi, Stefano Patarnello und 1 weitere

International Journal of Chronic Obstructive Pulmonary Disease · 2026-08 · Volume 21 · 1-15

DOI: 10.2147/copd.s598641 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2026-08. Verfasst von Nicoletta Di Giorgi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Generator RWD, UOS DWH, Sistemi Informativi Dipartimentali e della Ricerca, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Eosinophils, Antibodies, Monoclonal, Humanized, Pulmonary Eosinophilia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveEosinophilsAntibodies, Monoclonal, HumanizedPulmonary EosinophiliaLungHumansRetrospective StudiesFemaleAgedMaleMiddle AgedTreatment OutcomeSeverity of Illness IndexItalyDisease ProgressionPatient Selection

Stichwörter der Autor:innen

COPD-exacerbationsbiologic therapychronic obstructive pulmonary diseasedisease severityreal-world evidence

Substanzen

Antibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Generator RWD, UOS DWH, Sistemi Informativi Dipartimentali e della Ricerca, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Sanofi s.r.l, Milan, Italy.
  • Gemelli Digital Medicine and Health, Rome, Italy.
  • Digital Health Manager, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Division of Pulmonary Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • UOC Pneumologia, Ospedale San Filippo Neri-ASL Roma 1, Rome, Italy.

ORCID-Profile: Nicoletta Di Giorgi, Ilaria Barisone, Angela Nervoso

Zitieren

APA

Di Giorgi, N., Barisone, I., Nour, J., Moretti, D., Pagliai, A., Cesario, A., Nervoso, A., Coppola, A., Pompei, E., Iacomini, C., Masciocchi, C., Patarnello, S., & Macagno, F. (2026). Real-World Identification of Eosinophilic COPD Patients Potentially Eligible for Dupilumab: A Retrospective Observational Study. International Journal of Chronic Obstructive Pulmonary Disease, Volume 21, 1-15. https://doi.org/10.2147/copd.s598641

Vancouver

Di Giorgi N, Barisone I, Nour J, Moretti D, Pagliai A, Cesario A, et al. Real-World Identification of Eosinophilic COPD Patients Potentially Eligible for Dupilumab: A Retrospective Observational Study. International Journal of Chronic Obstructive Pulmonary Disease. 2026;Volume 21:1-15. doi:10.2147/copd.s598641

BibTeX
@article{DiGiorgi2026,
  author = {Di Giorgi, Nicoletta and Barisone, Ilaria and Nour, Jasmine and Moretti, Devis and Pagliai, Andrea and Cesario, Alfredo and Nervoso, Angela and Coppola, Angelo and Pompei, Edoardo and Iacomini, Chiara and Masciocchi, Carlotta and Patarnello, Stefano and Macagno, Francesco},
  title = {Real-World Identification of Eosinophilic COPD Patients Potentially Eligible for Dupilumab: A Retrospective Observational Study},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2026},
  volume = {Volume 21},
  pages = {1--15},
  doi = {10.2147/copd.s598641}
}
Kostenlos starten →